Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy

類似資料

• Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients
  著者:: Brandi, Giovanni, 等
  出版事項: (2016)
• Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase
  著者:: Roman, Nicholas O., 等
  出版事項: (2010)
• Identification of Non-nucleoside Human Ribonucleotide Reductase Modulators
  著者:: Ahmad, Md. Faiz, 等
  出版事項: (2015)
• Modulation of the Ribonucleotide Reductase M1 – Gemcitabine Interaction in vivo by N-ethylmaleimide
  著者:: Chen, Zhengming, 等
  出版事項: (2011)
• Human equilibrative nucleoside transporter-1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression; do they have survival impact to pancreatic cancer?
  著者:: Hwang, Dae Wook, 等
  出版事項: (2020)